Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP)-CE23-008, Research Grants To Develop and Validate a Prognostic Tool of Mental Health Sequelae After Traumatic Brain Injury for Adolescent Patients (U01); Amended Notice of Closed Meeting

Primary source

Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.

Published

March 8, 2023

Issuing agencies

Health and Human Services DepartmentCenters for Disease Control and Prevention

Full Text

<html>
<head>
<title>Federal Register, Volume 88 Issue 45 (Wednesday, March 8, 2023)</title>
</head>
<body><pre>
[Federal Register Volume 88, Number 45 (Wednesday, March 8, 2023)]
[Notices]
[Page 14372]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2023-04696]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Disease, Disability, and Injury Prevention and Control Special 
Emphasis Panel (SEP)--CE23-008, Research Grants To Develop and Validate 
a Prognostic Tool of Mental Health Sequelae After Traumatic Brain 
Injury for Adolescent Patients (U01); Amended Notice of Closed Meeting

    Notice is hereby given of a change in the meeting of the Disease, 
Disability, and Injury Prevention and Control Special Emphasis Panel 
(SEP)--CE23-008, Research Grants to Develop and Validate a Prognostic 
Tool of Mental Health Sequelae After Traumatic Brain Injury for 
Adolescent Patients (U01), March 14, 2023, 8:30 a.m., EDT-5:30 p.m., 
EDT, Web Conference, in the original FRN. The meeting was published in 
the Federal Register on January 20, 2023, Volume 88, Number 13, page/s/ 
3743.
    The meeting is being amended to begin the meeting later and should 
read as follows:
    Date: March 14, 2023.
    Time: 10:00 a.m.-6:00 p.m. (EDT).
    Place: Videoconference.
    The meeting is closed to the public.

FOR FURTHER INFORMATION CONTACT: Carlisha Gentles, PharmD, BCPS, CDCES, 
Scientific Review Officer, National Center for Injury Prevention and 
Control, CDC, 4770 Buford Highway NE, Mailstop F-63, Atlanta, Georgia 
30341, Telephone: (770)488-1504; Email: <a href="/cdn-cgi/l/email-protection#d79490b2b9a3bbb2a497b4b3b4f9b0b8a1"><span class="__cf_email__" data-cfemail="5615113338223a33251635323578313920">[email&#160;protected]</span></a>.
    The Director, Strategic Business Initiatives Unit, Office of the 
Chief Operating Officer, Centers for Disease Control and Prevention, 
has been delegated the authority to sign Federal Register notices 
pertaining to announcements of meetings and other committee management 
activities, for both the Centers for Disease Control and Prevention and 
the Agency for Toxic Substances and Disease Registry.

Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief 
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2023-04696 Filed 3-7-23; 8:45 am]
BILLING CODE 4163-18-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>

View on FederalRegister.gov →Plain-text source

Indexed from Federal Register on March 8, 2023.

This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.